Diabetes impairs recovery from noise-induced temporary hearing loss

Laryngoscope

Volumn 119, Issue 6, 2009, Pages 1190-1194

  Wu, Hung Pin ^a,b   Cheng, Tsun Jen ^a,c   Tan, Ching Ting ^c   Guo, Yueliang Leon ^a,c   Hsu, Chuan Jen ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Auditory brainstem response; Diabetes; Distortion product otoacoustic emission; Noise induced hearing loss; Temporary threshold shift

Indexed keywords

ISOPHANE INSULIN; STREPTOZOCIN;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIABETES MELLITUS; EVOKED BRAIN STEM AUDITORY RESPONSE; GLUCOSE BLOOD LEVEL; HEARING; HEARING LOSS; MALE; NOISE; NONHUMAN; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WISTAR RAT; ANIMAL; AUDITORY THRESHOLD; BRAIN STEM; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPONTANEOUS OTOACOUSTIC EMISSION;

ANIMALS; AUDITORY FATIGUE; BLOOD GLUCOSE; BRAIN STEM; DIABETES MELLITUS, EXPERIMENTAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; MALE; NOISE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, WISTAR;

EID: 66849093295     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20221     Document Type: Article

References (21)

1. Daniel E. Noise and hearing loss: a review. J Sch Health 2007; 77:225-231.
2. King H., Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21:1414-1431.
3. Kovar M. The inner ear in diabetes mellitus. ORL J Otorhinolaryngol Relat Spec 1973; 35:42-51.
4. Smith TL, Raynor E., Prazma J., Buenting JE, Pillsbury HC. Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 1995; 105:236-240.
5. Stolk RP, Boomsma LJ. Prevalence of deafness is increased in patients with type 2 diabetes in The Netherlands. Diabetes Care 1999; 22:180.
6. Varkonyi TT, Toth F., Rovo L., et al. Impairment of the auditory brainstem function in diabetic neuropathy. Diabetes Care 2002; 25:631-632.
7. Seidl R., Birnbacher R., Hauser E., Bernert G., Freilinger M., Schober E. Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM. Diabetes Care 1996; 19:1220-1224.
8. Rabinowitz PM. Noise-induced hearing loss. Am Fam Physician 2000; 61:2749-2756, 2759-2760.
9. Ishii EK, Talbott EO, Findlay RC, D'Antonio JA, Kuller LH. Is NIDDM a risk factor for noise-induced hearing loss in an occupationally noise exposed cohort? Sci Total Environ 1992; 127:155-165.
10. Hodgson MJ, Talbott E., Helmkamp JC, Kuller LH. Diabetes, noise exposure, and hearing loss. J Occup Med 1987; 29:576-579.
11. Chen YS, Tseng FY, Liu TC, Lin-Shiau SY, Hsu CJ. Involvement of nitric oxide generation in noise-induced temporary threshold shift in guinea pigs. Hear Res 2005; 203: 94-100.
12. Tan CT, Hsu CJ, Lee SY, Liu SH, Lin-Shiau SY. Potentiation of noise-induced hearing loss by amikacin in guinea pigs. Hear Res 2001; 161:72-80.
13. Mazurek B., Winter E., Fuchs J., Haupt H., Gross J. Susceptibility of the hair cells of the newborn rat cochlea to hypoxia and ischemia. Hear Res 2003; 182:2-8.
14. Di Nardo W., Ghirlanda G., Paludetti G., et al. Distortionproduct otoacoustic emissions and selective sensorineural loss in IDDM. Diabetes Care 1998; 21:1317-1321.
15. Mountain DC. Changes in endolymphatic potential and crossed olivocochlear bundle stimulation alter cochlear mechanics. Science 1980; 210:71-72.
16. Huang TJ, Price SA, Chilton L., et al. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003; 52:2129-2136.
17. Jeitler K., Horvath K., Berghold A., et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008; 51:941-951.
18. Bratusch-Marrain PR, Komjati M., Waldhausl WK. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 1986; 35:922-926.
19. Grubert JM, Lautz M., Lacy DB, et al. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake. Am J Physiol Endocrinol Metab 2005; 289:E232-E240.
20. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 2002; 512:121-134.
21. Tesch GH, Allen TJ. Rodent models of streptozotocininduced diabetic nephropathy. Nephrology (Carlton) 2007; 12:261-266.